This is a working overview of visceral adipose tissue, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-01-17 and is reviewed periodically as new material appears.
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
Published work tends to frame tesamorelin as a tool for studying the GHRH axis and as a compound with measurable effects on body composition. Reports often describe visceral adipose tissue as an endpoint, assessed by imaging rather than by inference. Analytical sections commonly describe liquid chromatography with tandem mass spectrometry to confirm identity and purity, because immunoassays may cross-react with related fragments. Where results diverge between studies, differences in assay choice, sampling timing, and population are frequent explanations offered. Whether effects persist after treatment stops remains an open question.
Tesamorelin binds the growth hormone–releasing hormone receptor on pituitary somatotroph cells. The receptor signals through the Gs protein, raising intracellular cAMP and activating protein kinase A. That cascade triggers release of stored growth hormone in pulses rather than a steady stream. Because the drug acts at the receptor that normally controls this process, its effect depends on the body's own signaling architecture rather than on a synthetic pathway. The resulting hormone profile reflects the timing of each pulse, not only its size.
| 性质 | 取值 | 备注 |
|---|---|---|
| 分子类型 | 合成四十四肽 | GHRH 类似物 |
| N 端修饰 | 反式-3-己烯酰基 | 延缓酶切 |
| 分子量 | 约 5135 Da | 依序列与修饰 |
| 受体靶点 | 垂体 GHRH 受体 | 经 cAMP 通路 |
| 常见同义名 | GHRH(1-44) 类似物 | 文献通用称法 |
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
The peptide is supplied as a lyophilized powder in single-use vials and is normally kept refrigerated between two and eight degrees Celsius, protected from light. Once dissolved, the solution is handled carefully because peptide bonds and the acyl modification can degrade under warm or alkaline conditions. Vials are inspected for cracks, and the powder is checked for color and uniformity before handling. Temperature excursions during shipping are a frequent reason for quality questions.
Identity and purity are assessed with reversed-phase high-performance liquid chromatography, which separates the peptide from truncated or oxidized forms. Mass spectrometry confirms the expected molecular weight, and peptide mapping after enzymatic digestion verifies the amino acid sequence. Water content is measured because residual moisture affects stability, and tests for aggregates or particulates are standard for injectable peptides. Circular dichroism can indicate whether the molecule has adopted an unexpected secondary structure in solution.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
The band performed three more shows, supporting Kiss on their reunion tour, with Staley's final live performance on July 3, 1996, in Kansas City, Missouri. Aside from recording two more songs with Alice in Chains – "Get Born Again" and "Died" – and a cover of Pink Floyd's "Another Brick in the Wall" with Class of '99 during 1998, Staley was out of the public spotlight by the late 1990s. Staley struggled with drug addiction and depression for much of his adult life; he later died from a speedball overdose on April 5, 2002, at the age of 34. He was ranked at No. 27 on Hit Parader's list of "Heavy Metal's All-Time Top 100 Vocalists" in 2006, and at No. 42 on Complex magazine's list of "The 50 Best Lead Singers of All Time" in 2012. Seattle officially declared August 22, 2019, as "Layne Staley Day". Staley earned six Grammy Award nominations as a member of Alice in Chains.
Like ethylene glycol and propylene glycol, glycerol is a non-ionic kosmotrope that forms strong hydrogen bonds with water molecules, competing with water-water hydrogen bonds. This interaction disrupts the formation of ice. The minimum freezing point temperature is about −38 °C (−36 °F) corresponding to 70% glycerol in water. Glycerol was historically used as an anti-freeze for automotive applications before being replaced by ethylene glycol, which has a lower freezing point. While the minimum freezing point of a glycerol-water mixture is higher than an ethylene glycol-water mixture, glycerol is not toxic and is being re-examined for use in automotive applications. In the laboratory, glycerol is a common component of solvents for enzymatic reagents stored at temperatures below 0 °C (32 °F) due to the depression of the freezing temperature. It is also used as a cryoprotectant where the glycerol is dissolved in water to reduce damage by ice crystals to laboratory organisms that are stored in frozen solutions, such as fungi, bacteria, nematodes, and mammalian embryos. Some organisms like the moor frog produce glycerol to survive freezing temperatures during hibernation.
=== Pharmacodynamics === Oxa-noribogaine acts as an atypical κ-opioid receptor (KOR) partial agonist similarly to noribogaine but shows dramatically increased potency and selectivity compared to noribogaine (EC50Tooltip half-maximal effective concentration = 43 nM vs. 6,100 nM, respectively; 142-fold difference). It produces analgesic effects in animals, but unlike conventional KOR agonists, does not produce aversive or pro-depressive effects. The drug induces a robust KOR-dependent increase in GDNF levels in the ventral tegmental area (VTA) and medial prefrontal cortex (mPFC). After a single dose or short-term treatment, oxa-noribogaine induces long-lasting suppression of opioid drug-seeking behavior in rodent relapse models. It also counteracts persistent opioid-induced hyperalgesia. In addition, oxa-noribogaine decreases alcohol consumption in rodents.
=== Daniel Van Deventer === Daniel Van Deventer (Alex Akpobome), nicknamed “DVD,” is a Pierpoint trader transferred from New York to London during plans to consolidate the two offices. A former protégé of Eric Tao, DVD’s rapid rise places him in direct competition with Eric, ultimately contributing to Eric’s demotion after the loss of Felim Bichan as a client. DVD assumes Eric’s responsibilities as CPS MD and begins a sexual relationship with Harper, encouraging her to consider relocating to New York as the London office faces closure. He later suspends Harper after secretly listening in on a call in which she helps Jesse Bloom unload positions at Pierpoint’s expense. DVD grows disillusioned with Pierpoint after being instructed by Adler to ignore Nicole Craig’s sexual assault of Venetia Berens, and sympathizes with Harper upon learning she was also assaulted by Nicole. He agrees to leave the firm with Harper, Eric, and Rishi, but is ultimately betrayed when Harper and Eric strike a deal with Adler to preserve a reduced London operation by branding DVD and Rishi as disloyal. DVD is fired along with much of the London office, discovering his dismissal only when his security badge stops working.
== Production == Unlike other aptamers, L-RNA aptamers are not directly made using systematic evolution of ligands by exponential enrichment (SELEX), as L-nucleic acids are not amenable to enzymatic methods, such as polymerase chain reaction (PCR), used in SELEX. Therefore, the selection is done with mirrored target molecules.
Sources: en.wikipedia.org
The developer of the Half-Life series, Valve, was founded in 1996 in Kirkland, Washington by the former Microsoft employees Mike Harrington and Gabe Newell. Valve began working on the first Half-Life soon after formation, and settled on a concept for a horror-themed 3D action game, using the Quake engine as licensed by id Software. The game was a hit at the 1997 E3 convention, where its animation system and artificial intelligence were demonstrated. The success led to its first expansion pack, Half-Life: Opposing Force, which was developed by Gearbox Software, a new company based in Plano, Texas, and announced on April 15, 1999. The Gearbox founder, Randy Pitchford, said Valve gave them the project to allow Valve to focus on future games. Opposing Force was demonstrated at the 1999 E3 convention, where new locations, characters and the story were revealed. The second Half-Life expansion pack, Half-Life: Blue Shift, was again developed by Gearbox Software and announced by its publisher, Sierra Entertainment, on August 30, 2000. Sierra intended to release Blue Shift for the Dreamcast, and it was set to include higher detail models and textures that were double the polygon count of the models from Half-Life. However, after several months of delays, Sierra terminated the Dreamcast version of Blue Shift on June 16, 2001, and instead released it for Windows on June 12. Afterward, Gearbox began working on a Half-Life game for the PlayStation 2.
===== India, Russia and CIS countries ===== Valparin Chrono by Sanofi India Valprol CR by Intas Pharmaceutical (India) Encorate Chrono by Sun Pharmaceutical (India) Serven Chrono by Leeven APL Biotech (India)
The transition to democracy took place in the early years of his reign, making Spain no longer the only non-communist dictatorship left in Europe. The new king assumed the project of the reformist sector of Franco's political elite that, facing the conservatives, defended the need to introduce gradual changes in the fundamental laws so that the new monarchy would be accepted in Europe as a whole. This project was the one that his first government tried to implement, and it was presided by Carlos Arias Navarro, who had already headed the last government of General Franco. However, in view of the incapacity demonstrated by Arias Navarro, Juan Carlos appointed in July 1976 the Francoist "reformist" Adolfo Suárez as the new Head of Government to lead the process of transition to democracy without any "rupture" with the "previous regime". This is how the Political Reform Act came about, which was approved by the Francoist Cortes and revalidated in the referendum of December 1976. According to this new fundamental law, free elections to democratically elected Cortes were to be called. Suarez's problem was to get the "controlled" transition process established in the Political Reform Act accepted by the democratic opposition, since the latter, in exchange for abandoning the "democratic rupture" and participating in the elections, demanded that Franco's institutions be dismantled and that all parties without exception ─ including the Communist Party of Spain ─ be legalized.
"Hem. Marker study, ADULTS over 16 years;Asc";Hem. Marker examination, ADULTS over 16 years, Ascites fluid;Hematology marker laboratory "Erythrocytes;Asc";"Asc-Erythrocytes; count";Clinical Biochemistry Laboratory "Erythrocytes;Asc";"Asc-Erythrocytes; numberk";, Clinical Biochemistry Laboratory "Leukocytes(mononuclear);Asc";"Asc-Leukocytes(mononuclear); count";Clinical Biochemistry Laboratory "Leukocytes(polynucleus);Asc";"Asc-Leukocytes(polynucleus); count";Clinical Biochemistry Laboratory "Nucleated cells;Asc";"Asc-Nucleated cells; count";Clinical Biochemistry Laboratory "Nucleated cells;Asc";"Asc-Nucleated cells; numberk";Clinical Biochemistry Laboratory "Carbamide;Asc";"Asc-Carbamide; substancek";Clinical Biochemistry Laboratory "Calcium;Asc";"Asc-Calcium(II); substance c.";Clinical Biochemistry Laboratory "Phosphate;Asc";"Asc-Phosphate(P; inorganic); substance";Clinical Biochemistry Laboratory "Triglyceride;Asc";"Asc-Triglyceride; substance";Clinical Biochemistry Laboratory "Bilirubins;Asc";Asc-Bilirubins, substance;Clinical Biochemistry Laboratory "Albumin;Asc";"Asc-Albumin; bulk";Clinical Biochemistry Laboratory "Protein;Asc";"Asc-Protein; mass spec.";Clinical Biochemistry Laboratory "Amylase, pancreatic type;Asc";"Asc-Amylase, pancreatic type;cat.k.";Clinical Biochemistry Laboratory "Lactate dehydro ase;Asc";"Asc-Lactate dehydro ase;.";Clinical Biochemistry Laboratory "Cholesterol;Asc";"Asc-Cholesterol+ester; substance c.";Clinical Biochemistry Laboratory "Ascites group;Asc";"A Alternative list for Ascites fluid analyses: The following analyses (Normal Order Name; Designation in the laboratory; Laboratory) can be performed on the sample material Ascites fluid.
Sources: en.wikipedia.org
tesamorelin 属 GHRH 类似物，作用于垂体受体以促进内源生长激素释放；生长激素本身是直接补充的外源激素。两者在给药逻辑、作用位点和反馈调控路径上并不相同。
作为多肽，它难以通过胃肠道吸收，通常需要注射给药。口服会因消化酶降解而失去活性，因此文献中讨论的都是注射途径。
公开研究多集中在内脏脂肪、体成分分布以及与生长激素轴相关的代谢指标。长期安全性和在普通人群中的适用性尚缺乏一致结论。
It acts on the growth hormone–releasing hormone receptor, a Gs-coupled receptor found on pituitary somatotroph cells. Activation raises cAMP and prompts pulsatile hormone release.